PortfoliosLab logoPortfoliosLab logo
MDEV vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MDEV vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Indxx Medical Devices ETF (MDEV) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDEV achieves a -9.68% return, which is significantly lower than XLVI's 1.35% return.


MDEV

1D
2.04%
1M
3.02%
YTD
-9.68%
6M
-10.44%
1Y
-5.82%
3Y*
-2.19%
5Y*
10Y*

XLVI

1D
2.03%
1M
4.01%
YTD
1.35%
6M
3.19%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDEV vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between MDEV and XLVI is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.66

MDEV vs. XLVI - Sectors Allocation Comparison


Sectors
MDEV
XLVI

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

100.6%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

MDEV
100.0%
XLVI

-

Basic Materials

MDEV

-

XLVI

-

Communication Services

MDEV

-

XLVI

-

Consumer Cyclical

MDEV

-

XLVI

-

Consumer Defensive

MDEV

-

XLVI

-

Energy

MDEV

-

XLVI

-

Financial Services

MDEV

-

XLVI
100.6%

Industrials

MDEV

-

XLVI

-

Real Estate

MDEV

-

XLVI

-

Technology

MDEV

-

XLVI

-

Utilities

MDEV

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDEV vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDEV
MDEV Risk / Return Rank: 66
Overall Rank
MDEV Sharpe Ratio Rank: 66
Sharpe Ratio Rank
MDEV Sortino Ratio Rank: 55
Sortino Ratio Rank
MDEV Omega Ratio Rank: 66
Omega Ratio Rank
MDEV Calmar Ratio Rank: 66
Calmar Ratio Rank
MDEV Martin Ratio Rank: 55
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDEV vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MDEVXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.95

Calmar ratioReturn relative to maximum drawdown

-0.32

Martin ratioReturn relative to average drawdown

-0.80

MDEV vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


MDEVXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.36

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.30

1.54

-1.84

Drawdowns

MDEV vs. XLVI - Drawdown Comparison

The maximum MDEV drawdown since its inception was -42.34%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for MDEV and XLVI.


Loading charts...

Drawdown Indicators


MDEVXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-42.34%

-8.14%

-34.20%

Max Drawdown (1Y)

Largest decline over 1 year

-18.13%

Max Drawdown (3Y)

Largest decline over 3 years

-22.50%

Current Drawdown

Current decline from peak

-32.41%

-2.08%

-30.33%

Average Drawdown

Average peak-to-trough decline

-25.66%

-1.95%

-23.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.26%

Volatility

MDEV vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


MDEVXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.98%

Volatility (6M)

Calculated over the trailing 6-month period

11.61%

Volatility (1Y)

Calculated over the trailing 1-year period

16.14%

11.12%

+5.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.00%

11.12%

+7.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.00%

11.12%

+7.88%

MDEV vs. XLVI - Expense Ratio Comparison

MDEV has a 0.70% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

MDEV vs. XLVI - Dividend Comparison

MDEV has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.30%.


Frequently Asked Questions


MDEV and XLVI have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.70% for MDEV.

XLVI has the higher dividend yield at 11.30%, compared with 0.00% for MDEV.

MDEV is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.70% for MDEV and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for MDEV and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer